Democratic News Hubb
Advertisement
  • Home
  • News
  • Democratic
  • Contact us
No Result
View All Result
  • Home
  • News
  • Democratic
  • Contact us
No Result
View All Result
Democratic News Hubb
No Result
View All Result
Home Democratic

China approves first domestic mRNA COVID-19 vaccine | Coronavirus pandemic News

admin by admin
March 22, 2023
in Democratic


In a study of 4,000 participants, the vaccine showed efficacy of 85.3 percent 14 to 28 days after a booster vaccination.

China has approved its first domestically developed mRNA vaccine against COVID-19, its manufacturer said on Wednesday, months after the relaxation of strict zero-COVID regulations sparked a surge in cases.

The vaccine, developed by CSPC Pharmaceutical Group Ltd, has been approved for “emergency use” by Beijing’s health regulator, the company said in a statement on Wednesday.

It showed high efficacy in a trial in which it was used as a booster shot for people who have been given other types of vaccines, the company added, without offering further details.

China, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vaccines using messenger RNA (mRNA) technology since early 2020.

While traditional vaccines use a weakened or inactivated germ to prepare the body for a future attack from the real virus, mRNA deploys snippets of genetic material that carry instructions showing the body’s cells how to produce a protein – in this case, the spike protein on the coronavirus that causes COVID.

The body’s immune system then triggers antibodies to fight off that spike protein, making it ready for when the real coronavirus invades.

The long-awaited approval

The long-awaited approval came as infections have fallen sharply across China since it suddenly dropped its strict “zero-COVID” curbs in December, making the sales outlook for the newly approved vaccine moderate.

But it would give China an additional option to tackle future outbreaks and a base for development against newly emerging variants, scientists said.

The news of China’s first successful mRNA vaccine did not generate much buzz in domestic social media on Wednesday, as the country has returned to normal and its borders have re-opened.

Its top leaders declared a “decisive victory” over COVID last month.

CSPC said its vaccine trials showed adverse effects were substantially lower in an elderly group compared with an adult group, boosting Chinese efforts to protect its vulnerable elderly population.

The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed good neutralisation effect against Omicron subvariants BA.5, BF.7, BQ.1.1., XBB.1.5 and CH.1.1. in clinical trials.

In a study of 4,000 participants from December 10 to January 18 when China was experiencing a surge in infections, the vaccine showed efficacy of 85.3 percent 14 to 28 days after a booster vaccination.

CSPC did not say how many doses it plans to produce. It said the vaccine could be stored at 2 to 8 C (35.6 degrees to 46.4 degrees F) for a long time.

The firm won emergency approval for clinical trials of the mRNA shot in April last year, around the same time as CanSino, another China-based company that is testing an mRNA Omicron booster shot.



Source link

Tags: Asia PacificChinaCoronavirus pandemicNews
Previous Post

Fake news has capacity to destroy democracy, says CJI Chandrachud, wants ‘selective quoting of judges’ to stop

Next Post

Priorities for rail safety bill debated in U.S. Senate hearing with Norfolk Southern CEO

Next Post

Priorities for rail safety bill debated in U.S. Senate hearing with Norfolk Southern CEO

Recommended

Disney is ending plans to move jobs to Florida as battle heats up | Business and Economy News

May 18, 2023

State takeover of St. Louis police, prosecutor’s office blocked by Senate Democrats • Missouri Independent

May 3, 2023

The forever war on Julian Assange | Opinions

May 14, 2023

At least 11 killed in Pakistan avalanche | News

May 27, 2023

Don't miss it

Democratic

Why has the conviction of Senegal’s Sonko sparked such anger? | TV Shows

June 2, 2023
Democratic

Jaishankar, Brazilian counterpart hold talks on advancing cooperation in BRICS, IBSA, G20 blocs – ThePrint –

June 2, 2023
News

Iran Is Eyeing World Domination, Former Israeli General Warns

June 2, 2023
News

Half a million people in less than a dozen states have lost Medicaid coverage since April • Missouri Independent

June 2, 2023
News

Idaho’s physician shortage is here. Here’s what we can do about it.

June 2, 2023
Democratic

Does artificial intelligence pose the risk of human extinction? | TV Shows

June 1, 2023
Democratic

India’s comparative advantage in investing in Nepal cannot be overstated: Prachanda – ThePrint –

June 1, 2023
Democratic

Budget request OK’d as Ryan Walters chairs first meeting of overhauled state Board of Education

June 1, 2023
democratic-white

© Democratic News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Democratic
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Democratic
  • Contact us

© 2022 Democractic News Hubb All rights reserved.